Corrigendum: Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager.

Frontiers in Immunology（2024）

引用 0|浏览15

暂无评分

摘要

[This corrects the article DOI: 10.3389/fimmu.2023.1113303.].

查看译文

关键词

NK-cell engager,T-cell engager,tumor immunotherapy,antitumor,proinflammatory cytokines

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要